Description
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide fragment of the soluble IL-6 receptor binds IL-6 weakly but does not display significant downstream signaling effects. This peptide may be used to measure presence of IL-6 or immunomodulation by other compounds.
| Purity | ≥95% |
|---|---|
| Formula | C51H85N13O21 |
| Formula Wt. | 1216.32 |
| Synonym | IL-6R |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Bosze S, Hudecz F, Igaz P, et al. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells. Biol Chem. 2003 Mar;384(3):409-21. PMID: 12715892.
Steroid; glucocorticoid agonist.
Akt inhibitor.
Endogenous peptide, involved in hormone regulat...
Wnt signaling inhibitor.
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Found in Evodia rutaecarpa; potential cAMP, 3β...
Cysteine-ITC conjugate, BITC derivative, antiox...
Triterpene saponin found in species of Panax; P...
Peptide, protease substrate.
L-type Ca2+ channel blocker.
Fluoroquinolone; topoisomerase IV and bacterial...
Hydrophobic β-lactam; penicillin binding prote...
Endogenous peptide hormone, involved in water h...
Indoline; PDGFR, VEGFR, c-KIT, FLT3, mTORC1 inh...
Pentacyclic triterpene.
PI3K inhibitor.
Peptide, vasopressin analog; V1/2 agonist.
Inhibitor of EGFR.
BRD inhibitor.